Literature DB >> 20091801

Homocysteine metabolism and its relation to health and disease.

Kelly T Williams1, Kevin L Schalinske.   

Abstract

Homocysteine is a metabolic intermediate in methyl group metabolism that is dependent on a number of nutritional B-vitamin cofactors. An emerging aspect of homocysteine metabolism is its relation to health and disease. Perturbations of homocysteine metabolism, particularly intracellular and subsequently circulating accumulation of homocysteine (i.e., hyperhomocysteinemia), are associated with vascular disease risk, as well as other pathologies. However, intervention with B-vitamin supplementation has been shown to successfully restore normal homocysteine concentrations, but without concomitant reductions in disease risk. Thus, the mechanistic relation between homocysteine balance and disease states, as well as the value of homocysteine management, remains an area of intense investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091801     DOI: 10.1002/biof.71

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  28 in total

1.  Chronic mild hyperhomocysteinemia alters ectonucleotidase activities and gene expression of ecto-5'-nucleotidase/CD73 in rat lymphocytes.

Authors:  Emilene B S Scherer; Luiz Eduardo B Savio; Fernanda C Vuaden; Andréa G K Ferreira; Maurício R Bogo; Carla D Bonan; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2011-11-02       Impact factor: 3.396

Review 2.  Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.

Authors:  Ammar Hassanzadeh Keshteli; Vickie E Baracos; Karen L Madsen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 3.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

Review 4.  Homocysteine as a Pathological Biomarker for Bone Disease.

Authors:  Jyotirmaya Behera; Jyoti Bala; Mohammed Nuru; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cell Physiol       Date:  2017-04-12       Impact factor: 6.384

Review 5.  Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Authors:  Yi Fu; Xian Wang; Wei Kong
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

Review 6.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

7.  Severe Hyperhomocysteinemia Decreases Respiratory Enzyme and Na(+)-K(+) ATPase Activities, and Leads to Mitochondrial Alterations in Rat Amygdala.

Authors:  Janaína Kolling; Emilene B S Scherer; Cassiana Siebert; Aline Longoni; Samanta Loureiro; Simone Weis; Letícia Petenuzzo; Angela T S Wyse
Journal:  Neurotox Res       Date:  2015-12-22       Impact factor: 3.911

8.  Homocysteine pre-treatment increases redox capacity in both endothelial and tumor cells.

Authors:  Elena Díaz-Santiago; Luis Rodríguez-Caso; Casimiro Cárdenas; José J Serrano; Ana R Quesada; Miguel Ángel Medina
Journal:  Redox Rep       Date:  2016-05-19       Impact factor: 4.412

9.  Homocysteine, cysteine, folate and vitamin B₁₂ status in type 2 diabetic patients with chronic kidney disease.

Authors:  Anna Pastore; Annalisa Noce; Gianna Di Giovamberardino; Alessandro De Stefano; Cinzia Callà; Rossella Zenobi; Mariarita Dessì; Nicola Di Daniele
Journal:  J Nephrol       Date:  2014-08-06       Impact factor: 3.902

10.  Age-related cataracts: homocysteine coupled endoplasmic reticulum stress and suppression of Nrf2-dependent antioxidant protection.

Authors:  Rajan Elanchezhian; Periyasamy Palsamy; Christian J Madson; David W Lynch; Toshimichi Shinohara
Journal:  Chem Biol Interact       Date:  2012-09-01       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.